Pro‐Inflammatory c ‐Met + CD4 T Cells in Multiple Sclerosis
Annals of Neurology · 2026-01 · 99 (1) · 261-273
DOI: 10.1002/ana.78035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, online erschienen am 26.09.2025. Verfasst von Gautier Breville und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neurosciences, Division of Neurology, University Hospital of Geneva, Geneva, Switzerland. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, Proto-Oncogene Proteins c-met, Multiple Sclerosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.
Abstract (Originalsprache)
Objective
Hepatocyte growth factor (HGF) binds exclusively the c‐Met surface receptor, and the HGF/c‐Met axis regulates T cell function in autoimmune diseases. We analyzed c‐Met expression on human CD4 T cells in the blood and cerebrospinal fluid (CSF) from patients with multiple sclerosis (MS) versus non‐inflammatory neurological disease (NIND), to better understand the role of CD4 T cells in MS.
Methods
We recruited 34 untreated MS patients (age 28–44 years) and 13 NIND (age 34–51 years) who underwent paired blood and CSF sampling at the time of diagnosis work‐up. Phenotypic and functional CD4 T cells characterization was determined by flow cytometry and bulk RNA sequencing. Adhesion and transmigration capacities were studied to further characterize the function of c‐Met + CD4 T cells. Results c‐Met + memory CD4 T cells were detected at higher levels in both blood (median of 1.98%) and CSF (5.88%) in MS compared to NIND (0.37% and 0.68%, respectively) ( p < 0.0001). Ex vivo c‐Met + CD4 T cells exhibited higher levels of GM‐CSF, interleukin (IL)‐17, interferon (IFN)‐, and double positive IL‐17 + IFN‐ + expression, compared with c‐Met − CD4 T cells. c‐Met + CD4 T cells expressed increased levels of integrins—Itgα4β1 (VLA‐4) and ItgαLβ2 (LFA‐1)—compared with c‐Met − CD4 T cells. Anti‐Itgα4 (natalizumab) and anti‐ItgαLβ2 (odulimomab) inhibited CD4 T cell transmigration with predominant inhibition of CD4 T cells expressing c‐Met.
Interpretation
These results emphasize c‐Met as an immune marker of highly pro‐inflammatory and migratory CD4 T lymphocytes in both the periphery and central nervous system of MS patients. ANN NEUROL 2026;99:261–273
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Neurosciences, Division of Neurology, University Hospital of Geneva, Geneva, Switzerland.
- Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
- Geneva Centre for Inflammation Research, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
- Center for Neuroinflammation and Experimental Therapeutics, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
ORCID-Profile: Gautier Breville, Mahdia Benkhoucha
Förderung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Zitieren
APA
Breville, G., Benkhoucha, M., Rezk, A., Tran, N. L., Senoner, I., Bar-Or, A., & Lalive, P. H. (2026). Pro‐Inflammatory c ‐Met + CD4 T Cells in Multiple Sclerosis. Annals of Neurology, 99(1), 261-273. https://doi.org/10.1002/ana.78035
Vancouver
Breville G, Benkhoucha M, Rezk A, Tran NL, Senoner I, Bar-Or A, et al. Pro‐Inflammatory c ‐Met + CD4 T Cells in Multiple Sclerosis. Annals of Neurology. 2026;99(1):261-273. doi:10.1002/ana.78035
BibTeX
@article{Breville2026,
author = {Breville, Gautier and Benkhoucha, Mahdia and Rezk, Ayman and Tran, Ngoc Lan and Senoner, Isis and Bar-Or, Amit and Lalive, Patrice H},
title = {Pro‐Inflammatory c ‐Met + CD4 T Cells in Multiple Sclerosis},
journal = {Annals of Neurology},
year = {2026},
volume = {99},
number = {1},
pages = {261--273},
doi = {10.1002/ana.78035}
}
EUVIMED